In our study, the abnormal hypermethylation of TMEM59L was associated with decreased mRNA levels and better clinical outcomes for several cancers, such as KIRP, KIRC, and COAD, suggesting that hypermethylation of TMEM59L gene may be key regulatory mechanism for TMEM59L expression in these cancers. The gene discussed is TMEM59L; the disease is cancer.